Paul Chadwick qualified in 1990 and gained an MSc (by research) in 2000. He completed a PhD in 2012 looking at the social construction of neuropathic pain. He is the Global Medical Affairs Director at Molnlycke Health Care. Most recently he was the EVP of Spectral AI and prior to that he was Interim Chief Executive at the Royal College of Podiatry where he led the development and implementation of the Organisation’s five-year strategic plan. Before starting at the Royal College, He was a consultant podiatrist, he led a team of clinical specialists and developed an integrated system wide approach to foot care. He maintains a clinical role as an honorary consultant podiatrist. He has presented nationally and internationally and published widely in many peer reviewed journals. Previously Paul was the Chair of Foot in Diabetes U.K. He is on the editorial board of a range of journals and has been appointed associate editor of the Diabetic Foot Journal. He has a Fellowship from the Royal College of Podiatry and was awarded the meritorious award in 2014 for services to the profession. He also received a Fellowship from the Royal College of Physicians and Surgeons of Glasgow. Paul was appointed Visiting Professor of Tissue Viability at Birmingham City University in 2018. In his time at The Royal College, he led many projects including, Workforce and Educational reform, HCPC annotation of podiatric surgery in England, the development of the Advanced Clinical Practice Framework in lower limb viability and the Diabetes Commissioning Tool Kit. He has also led the implementation of a new learning management system and created a suite of continuing professional development modules for the profession.